{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:56:54Z","timestamp":1794358614020,"version":"4.9.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001784","name":"Victoria University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI34616"],"award-info":[{"award-number":["P01AI34616"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R37AI051334"],"award-info":[{"award-number":["R37AI051334"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI63940"],"award-info":[{"award-number":["AI63940"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI144133"],"award-info":[{"award-number":["U19AI144133"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI42143"],"award-info":[{"award-number":["R01AI42143"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI18988"],"award-info":[{"award-number":["R01AI18988"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014789","name":"Washington State Department of Transportation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.vaccine.2022.11.002","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T20:42:04Z","timestamp":1668199324000},"page":"7676-7692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum"],"prefix":"10.1016","volume":"40","author":[{"given":"Sheila A.","family":"Lukehart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Molini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alloysius","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charmie","family":"Godornes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragan A.","family":"Pitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrick","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Giacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8786-4359","authenticated-orcid":false,"given":"Caroline E.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.11.002_b0005","article-title":"Syphilis","volume":"365","author":"O'Byrne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.vaccine.2022.11.002_b0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.14745\/ccdr.v44i02a02","article-title":"Infectious and congenital syphilis in Canada, 2010\u20132015","volume":"44","author":"Choudhri","year":"2018","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2022.11.002_b0015","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1017\/S0950268819000281","article-title":"The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe","volume":"147","author":"Spiteri","year":"2019","journal-title":"Epidemiol Infect"},{"issue":"22","key":"10.1016\/j.vaccine.2022.11.002_b0020","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1056\/NEJMicm1904420","article-title":"Congenital Syphilis","volume":"381","author":"Arrieta","year":"2019","journal-title":"N Engl J Med"},{"issue":"10154","key":"10.1016\/j.vaccine.2022.11.002_b0025","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(18)32360-2","article-title":"Lancet (ed). Congenital syphilis in the USA","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2022.11.002_b0030","doi-asserted-by":"crossref","first-page":"e0211720","DOI":"10.1371\/journal.pone.0211720","article-title":"Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012","volume":"14","author":"Korenromp","year":"2019","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.vaccine.2022.11.002_b0035","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S1473-3099(18)30618-2","article-title":"Congenital syphilis and other STIs rise in the USA","volume":"18","author":"Nelson","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.002_b0040","doi-asserted-by":"crossref","first-page":"17073","DOI":"10.1038\/nrdp.2017.73","article-title":"Syphilis","volume":"3","author":"Peeling","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.002_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/14760584.2016.1203262","article-title":"Vaccine development for syphilis","volume":"16","author":"Lithgow","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"14","key":"10.1016\/j.vaccine.2022.11.002_b0050","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.vaccine.2013.09.053","article-title":"Current status of syphilis vaccine development: need, challenges, prospects","volume":"32","author":"Cameron","year":"2014","journal-title":"Vaccine"},{"issue":"9S","key":"10.1016\/j.vaccine.2022.11.002_b0055","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/OLQ.0000000000000831","article-title":"Syphilis vaccine development: requirements, challenges and opportunities","volume":"45","author":"Cameron","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.002_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/CMR.19.1.29-49.2006","article-title":"Biological basis for syphilis","volume":"19","author":"LaFond","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2022.11.002_b0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-109-11-855","article-title":"Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment","volume":"109","author":"Lukehart","year":"1988","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.002_b0070","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S1473-3099(20)30838-0","article-title":"Treponema pallidum detection in lesion and non-lesion sites in men who have sex with men with early syphilis: a prospective, cross-sectional study","volume":"21","author":"Towns","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.002_b0075","doi-asserted-by":"crossref","first-page":"e3250","DOI":"10.1093\/cid\/ciaa1613","article-title":"A new specimen for syphilis diagnosis: evidence by high loads of Treponema pallidum DNA in saliva","volume":"73","author":"Wang","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2022.11.002_b0080","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00572-19","article-title":"Treponema pallidum nucleic acid amplification testing to augment syphilis screening among men who have sex with men","volume":"57","author":"Golden","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.002_b0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1086\/426510","article-title":"Treponema pallidum strain-specific differences in neuroinvasion and clinical phenotype in a rabbit model","volume":"191","author":"Tantalo","year":"2005","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.002_b0090","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1139\/m85-142","article-title":"Experimental congenital syphilis in rabbits","volume":"31","author":"Fitzgerald","year":"1985","journal-title":"Can J Microbiol"},{"issue":"Unit 12A.1","key":"10.1016\/j.vaccine.2022.11.002_b0095","article-title":"Isolation and laboratory maintenance of Treponema pallidum","volume":"Chapter 12","author":"Lukehart","year":"2007","journal-title":"Curr Protocols Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.002_b0100","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01153-18","article-title":"Long-term in vitro culture of the syphilis spirochete Treponema pallidum subsp. pallidum","volume":"9","author":"Edmondson","year":"2018","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.vaccine.2022.11.002_b0105","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1002\/cpz1.44","article-title":"In Vitro Cultivation of the Syphilis Spirochete Treponema pallidum","volume":"1","author":"Edmondson","year":"2021","journal-title":"Curr Protoc"},{"issue":"24","key":"10.1016\/j.vaccine.2022.11.002_b0110","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1128\/JB.01031-09","article-title":"Cryo-electron tomography elucidates the molecular architecture of Treponema pallidum, the syphilis spirochete","volume":"191","author":"Izard","year":"2009","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.002_b0115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jmb.2010.09.020","article-title":"Cellular Architecture of Treponema pallidum: Novel Flagellum, Periplasmic Cone, and Cell Envelope as Revealed by Cryo Electron Tomography","volume":"403","author":"Liu","year":"2010","journal-title":"J Mol Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.11.002_b0120","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1073\/pnas.86.6.2051","article-title":"Outer membrane ultrastructure explains the limited antigenicity of virulent Treponema pallidum","volume":"86","author":"Radolf","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.002_b0125","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/jb.171.9.5005-5011.1989","article-title":"Demonstration of rare protein in the outer membrane of Treponema pallidum subsp. pallidum by freeze-fracture analysis","volume":"171","author":"Walker","year":"1989","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.002_b0130","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/315399","article-title":"Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92","volume":"181","author":"Cameron","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.11.002_b0135","first-page":"8","article-title":"A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum","author":"Lithgow","year":"2017","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.vaccine.2022.11.002_b0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.micinf.2004.04.001","article-title":"Subfamily I Treponema pallidum repeat protein family: sequence variation and immunity","volume":"6","author":"Sun","year":"2004","journal-title":"Microbes Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2022.11.002_b0145","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1128\/IAI.70.12.6811-6816.2002","article-title":"Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model","volume":"70","author":"Morgan","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.002_b0150","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.189.4.647","article-title":"Treponema pallidum major sheath protein homologue Tpr K is a target of opsonic antibody and the protective immune response","volume":"189","author":"Centurion-Lara","year":"1999","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2022.11.002_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002222","article-title":"Fine analysis of genetic diversity of the tpr gene family among treponemal species, subspecies and strains","volume":"7","author":"Centurion-Lara","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2022.11.002_b0160","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00195-20","article-title":"Identification of the neuroinvasive pathogen host target, LamR, as an endothelial receptor for the Treponema pallidum adhesin Tp0751","volume":"5","author":"Lithgow","year":"2020","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.002_b0165","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/s41598-017-01589-4","article-title":"Identification of Tp0751 (pallilysin) as a Treponema pallidum vascular adhesin by heterologous expression in the Lyme disease spirochete","volume":"7","author":"Kao","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.002_b0170","doi-asserted-by":"crossref","first-page":"151553","DOI":"10.1016\/j.ijmm.2022.151553","article-title":"Treponema pallidum Tp0751 alters the expression of tight junction proteins by promoting bEnd3 cell apoptosis and IL-6 secretion","volume":"312","author":"Lu","year":"2022","journal-title":"Int J Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2022.11.002_b0175","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00323-19","article-title":"Evaluation of the protective ability of the Treponema pallidum subsp. pallidum Tp0126 OmpW homolog in the rabbit model of syphilis","volume":"87","author":"Haynes","year":"2019","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.002_b0180","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1128\/IAI.01083-10","article-title":"Bifunctional role of the Treponema pallidum extracellular matrix binding adhesin Tp0751","volume":"79","author":"Houston","year":"2011","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.002_b0185","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ilar.46.3.280","article-title":"Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants","volume":"46","author":"Stills","year":"2005","journal-title":"ILAR J"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.002_b0190","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/IAI.01124-06","article-title":"Quantitative analysis of tpr gene expression in Treponema pallidum isolates: Differences among isolates and correlation with T-cell responsiveness in experimental syphilis","volume":"75","author":"Giacani","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.002_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2007.04.002","article-title":"Quantitation of rabbit cytokine mRNA by real-time RT-PCR","volume":"38","author":"Godornes","year":"2007","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.vaccine.2022.11.002_b0200","doi-asserted-by":"crossref","first-page":"e36446","DOI":"10.1371\/journal.pone.0036446","article-title":"Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection","volume":"7","author":"Schnupf","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.002_b0205","first-page":"183","article-title":"Infectivity tests in syphilis","volume":"45","author":"Turner","year":"1969","journal-title":"Br J Vener Dis"},{"key":"10.1016\/j.vaccine.2022.11.002_b0210","series-title":"Biology of the Treponematoses","author":"Turner","year":"1957"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2022.11.002_b0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/clinids\/7-Supplement_2.S305","article-title":"Prospects for development of a treponemal vaccine","volume":"7","author":"Lukehart","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.002_b0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/14760584.5.1.67","article-title":"Progress towards an effective syphilis vaccine: the past, present and future","volume":"5","author":"Cullen","year":"2006","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2022.11.002_b0225","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.110.5.1206","article-title":"Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by \u03b3- irradiation","volume":"110","author":"Miller","year":"1973","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2022.11.002_b0230","first-page":"429","article-title":"Abortive treatment of syphilis; results obtained in the incubation, primary, and secondary stages of syphilis","volume":"33","author":"Alexander","year":"1949","journal-title":"Am J Syph Gonorrhea Vener Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2022.11.002_b0235","first-page":"711","article-title":"Therapy for incubating syphilis","volume":"218","author":"Schroeter","year":"1971","journal-title":"Effectiveness of gonorrhea treatment JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2022.11.002_b0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4049\/jimmunol.124.1.461","article-title":"Characterization of lymphocyte responsiveness in early experimental syphilis. II. Nature of cellular infiltration and Treponema pallidum distribution in testicular lesions","volume":"124","author":"Lukehart","year":"1980","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.11.002_b0245","first-page":"355","article-title":"Experimental syphilitic orchitis in rabbits: ultrastructural appearance of Treponema pallidum during phagocytosis and dissolution by macrophages in vivo","volume":"46","author":"Sell","year":"1982","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2022.11.002_b0250","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/IAI.01973-06","article-title":"CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis","volume":"75","author":"Leader","year":"2007","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2022.11.002_b0255","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/infdis\/173.2.491","article-title":"Primary and secondary syphilis lesions contain mRNA for Th1 cytokines","volume":"173","author":"Van Voorhis","year":"1996","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2022.11.002_b0260","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/iai.64.3.1048-1050.1996","article-title":"Lesions of primary and secondary syphilis contain activated cytolytic T cells","volume":"64","author":"Van Voorhis","year":"1996","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2022.11.002_b0265","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2353\/ajpath.2010.100277","article-title":"Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-\/IL-17-producing CD8+ T cells?","volume":"177","author":"Stary","year":"2010","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.11.002_b0270","doi-asserted-by":"crossref","first-page":"e1002822","DOI":"10.1371\/journal.ppat.1002822","article-title":"Activation and proteolytic activity of the Treponema pallidum metalloprotease, pallilysin","volume":"8","author":"Houston","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2022.11.002_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.691731","article-title":"Treponema pallidum disrupts VE-Cadherin intercellular junctions and traverses endothelial barriers using a cholesterol-dependent mechanism","volume":"12","author":"Lithgow","year":"2021","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.002_b0280","doi-asserted-by":"crossref","first-page":"e1008871","DOI":"10.1371\/journal.ppat.1008871","article-title":"Evidence that immunization with TP0751, a bipartite Treponema pallidum lipoprotein with an intrinsically disordered region and lipocalin fold, fails to protect in the rabbit model of experimental syphilis","volume":"16","author":"Luthra","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2022.11.002_b0285","series-title":"Sexually Transmitted Diseases","first-page":"141","article-title":"Immunology and pathogenesis of syphilis","author":"Lukehart","year":"1992"},{"issue":"6","key":"10.1016\/j.vaccine.2022.11.002_b0290","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1365-2958.2004.04086.x","article-title":"Gene conversion: a mechanism for generation of heterogeneity in the tprK gene of Treponema pallidum during infection","volume":"52","author":"Centurion-Lara","year":"2004","journal-title":"Mol Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.11.002_b0295","doi-asserted-by":"crossref","first-page":"e1005919","DOI":"10.1371\/journal.ppat.1005919","article-title":"The structure of Treponema pallidum Tp0751 (pallilysin) reveals a non-canonical lipocalin fold that mediates adhesion to extracellular matrix components and interactions with host cells","volume":"12","author":"Parker","year":"2016","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2201372X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2201372X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:32:23Z","timestamp":1778679143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2201372X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":59,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0264410X2201372X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}